Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Stromal interaction molecule 1 (STIM1) messenger RNA 3' untranslated region (3'UTR) is a critical regulatory segment of the transcript encoding the STIM1 protein, which serves as the primary calcium sensor in the endoplasmic reticulum (ER) [PMID: 16204170]. This region contains numerous binding sites for microRNAs (miRNAs) and RNA-binding proteins that dictate the stability and translation efficiency of the mRNA [PMID: 24631204]. By controlling STIM1 protein abundance, the 3'UTR indirectly modulates store-operated calcium entry (SOCE), a vital process for maintaining intracellular calcium homeostasis and signaling [PMID: 23933499]. In many cancers, such as colorectal and breast cancer, the loss of miRNA-mediated suppression at the 3'UTR leads to STIM1 overexpression, which drives tumor cell migration and survival [PMID: 28415615]. Furthermore, dysregulation of the STIM1 3'UTR has been linked to cardiovascular pathologies, including cardiac hypertrophy and pulmonary arterial hypertension [PMID: 25633927]. As a therapeutic target, the STIM1 3'UTR is being explored for intervention using antisense oligonucleotides (ASOs) and miRNA mimics designed to downregulate STIM1 in hyper-proliferative or inflammatory states [PMID: 21907143]. However, a significant therapeutic challenge is the potential for inducing immunodeficiency, as STIM1 is essential for T-cell activation via the calcium release-activated calcium (CRAC) channel [PMID: 16204170]. These RNA-targeted strategies offer a way to fine-tune calcium signaling more specifically than traditional small-molecule ion channel blockers, provided that delivery and off-target effects are managed.
Antisense inhibition or microRNA-mediated silencing of STIM1 expression to modulate store-operated calcium entry (SOCE).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stromal interaction molecule 1 messenger RNA 3' untranslated region (STIM1 mRNA 3'UTR) (STIM1 mRNA 3'UTR).